Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States

Under these agreements, Galderma has an exclusive license to commercialize Sol-Gel』s most advanced investigational drug products using Sol-Gel』s proprietary micro-encapsulation technology, in e…